Insurance coverage · 2026 formulary
Does Cigna cover Wegovy in 2026?
Short answer: yes on most commercial Cigna plans — Wegovy is Tier 3 through the Express Scripts PBM, with prior authorization required. Cigna is one of the more predictable PA approvers among the majors: no step therapy, simpler PA form than Aetna, 5-10 day turnaround.
Prior authorization criteria
- BMI documentation: ≥30 kg/m² alone, or ≥27 kg/m² with a weight-related comorbidity. Height + weight must be from within the last 12 months.
- Qualifying comorbidity: T2D, hypertension, dyslipidemia, OSA, CVD, osteoarthritis. Diagnosis code must be documented in the chart within the last year.
- Lifestyle-counseling note: prescriber documentation that diet/exercise counseling occurred. Cigna does NOT require the formal 6-month lifestyle-failure documentation Aetna asks for.
- Contraindication attestation: no personal or family history of medullary thyroid carcinoma or MEN 2.
Turnaround: 5-10 days for standard review, 72 hours expedited (urgent). Peer-to-peer review available if denied.
Cost with Cigna
| Path | Monthly out-of-pocket | Notes |
|---|---|---|
| Cigna + PA approved + savings card | $0-25 | Novo Nordisk WeGoTogether card, up to 12 months |
| Cigna + PA approved, no savings card | $30-100 | Standard Tier 3 copay |
| Cigna + PA denied | $500-700 | Cigna-negotiated cash rate; rare — usually switch to cash |
| Plan excludes weight-loss drugs | $149-499 | Best cash path via oral Wegovy ($149-299/mo Hims) or Novo direct ($499/mo) |
If Cigna denies your PA
Most Cigna Wegovy denials are documentation gaps, not substantive rejections. Read the denial letter carefully — the specific missing criterion is stated. Common issues:
- BMI documentation stale: get a fresh height/weight in your prescriber's chart, resubmit.
- Comorbidity code missing: your prescriber adds the ICD-10 code for the comorbidity (E11.9 T2D, I10 hypertension, E78.5 dyslipidemia, G47.33 OSA, I25.10 CVD).
- Lifestyle-counseling note absent: a single clinical note documenting diet + exercise conversation is enough. Not a full 6-month failure record.
- Substantive medical denial: peer-to-peer review with a Cigna medical director. Approval rate is high on second look for clear BMI ≥30 cases.
Self-funded employer plans (ERISA) can override these standard Cigna criteria. About 25-30% of large-employer plans still exclude weight-loss drugs entirely. Verify your specific plan via the number on the back of your Cigna card. Not medical or benefits advice.
If Cigna keeps denying — the cash paths
- Oral Wegovy via Hims: $149-299/month self-pay, same 25 mg semaglutide molecule as the injection.
- Novo Nordisk direct (injection): $499/month fixed price via WeGoTogether program, no insurance needed.
- Alternative on-label GLP-1: Zepbound self-pay via LillyDirect at $349-499/month (tirzepatide, comparable efficacy).
Affiliate disclosure: Glpverdict earns commission on referrals via partner links. Editorial ranking is independent.
Frequently asked
Does Cigna cover Wegovy in 2026?
Yes on most commercial Cigna plans — Wegovy is Tier 3 weight-management on the Express Scripts formulary Cigna uses. Prior authorization required. Cigna does NOT typically enforce step therapy for Wegovy (unlike Aetna for Zepbound), making it one of the more predictable PA approvers among major payers.
What are Cigna's prior authorization criteria for Wegovy?
Standard 2026 criteria: (1) BMI ≥30 alone, or ≥27 with a documented weight-related comorbidity (T2D, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease); (2) prescriber attestation of lifestyle-intervention counseling (Cigna asks for counseling documentation, not formal 6-month failure like Aetna); (3) MTC/MEN2 contraindication attestation. Turnaround typically 5-10 days.
How much does Wegovy cost with Cigna?
With PA approved: commercial copay $30-100/month depending on plan tier. Layer the Novo Nordisk WeGoTogether savings card and eligible commercial patients pay as low as $0-25/month for up to 12 months. Without coverage: Cigna-negotiated cash rate ~$500-700/month vs $1,638 list price.
What if Cigna denies my Wegovy PA?
Most Cigna Wegovy denials are documentation gaps rather than substantive denials — missing BMI date, unclear comorbidity code, or lifestyle-counseling note not in the chart. First step is usually a resubmission with cleaner documentation. First appeal within 60 days; peer-to-peer review is available and has high success rate on Cigna.
Does Cigna Medicare Advantage cover Wegovy?
For type 2 diabetes: yes (via the Ozempic indication route — Wegovy for T2D is off-label but often approved). For weight loss alone: no — Medicare Part D excludes weight-loss drugs by statute (1993 Social Security Act §1860D-2). The 2026 Medicare GLP-1 Bridge program at $50/month applies to Wegovy for patients with cardiovascular disease meeting the SELECT trial criteria.
Does Cigna cover Zepbound, Mounjaro, or Ozempic?
Zepbound: same weight-management PA path as Wegovy (no step therapy requirement typically). Mounjaro + Ozempic: covered on-label for type 2 diabetes with standard tier placement; off-label for weight loss is typically denied.
Which is easier to get approved through Cigna: Wegovy or Zepbound?
Wegovy is slightly more straightforward at Cigna in 2026 — the PA form is simpler and more consistently applied. Zepbound has the same basic criteria but PA reviewers occasionally still flag it as needing step therapy despite the formulary listing.
Last verified July 11, 2026. Formulary changes quarterly — check the Express Scripts PDL for definitive current status.